Concerning? However, it appears this peace was written to blame President Trump and to solicit more government research funding (Trump Derangement Syndrome?)!
"China has surpassed the United States and Europe in the development of sophisticated antibody therapeutics, according to an analysis by scientific consultants Silvia Crescioli and Janine Reichert. China’s biopharmaceutical industry has capitalized on government support for drug innovation to help bring enhanced antibody drugs, such as antibody-drug conjugates (ADCs) and bispecific and multispecific antibodies, to market. The global clinical pipeline currently includes close to 500 enhanced antibody drugs, over half of which were created by Chinese companies. ..."
"During the past decade, the biopharmaceutical industry in China has been transformed by government policies designed to support innovation and modernize drug discovery, development and review processes. Biopharmaceutical companies in China have used this support to create platforms for the development of highly sophisticated drugs such as antibody–drug conjugates (ADCs) and bispecific and multispecific antibodies.
Here, we examine trends in the development of such ‘enhanced’ antibody therapeutics in China compared with the USA and Europe, particularly in the past decade (2015–2024). ...
Our analysis provides evidence that China’s recent focus on policy-driven innovation has enabled companies based there to surpass those in the USA and Europe in the development of sophisticated antibody therapeutics. The USA and Europe are thus at a competitive disadvantage in this area, and the USA, in particular, is not well positioned to respond, given the recent reductions in the workforce at key government agencies, such as the Food and Drug Administration and the National Institutes of Health, and the defunding of scientific programmes. ..."
No comments:
Post a Comment